Camut Christopher C 4
4 · PHARMATHENE, INC · Filed Jul 30, 2009
Insider Transaction Report
Form 4
Camut Christopher C
VP, Chief Financial Officer
Transactions
- Award
10% Unsecured Convertible Note
2009-07-28Exercise: $2.54From: 2009-07-28Exp: 2011-07-28→ Common Stock (3,934 underlying) - Award
Common Stock Warrant
2009-07-28+1,333→ 1,333 totalExercise: $2.50From: 2010-01-28Exp: 2015-01-28→ Common Stock (1,333 underlying)
Footnotes (1)
- [F1]This Note and Warrant were received in an exempt transaction pursuant to a Note and Warrant Purchase Agreement dated as of July 24, 2009, as amended as of July 26, 2009 and July 28, 2009, by and among the Issuer and certain investors (the "Agreement"). Pursuant to the Agreement, the Reporting Person received a 10% Unsecured Convertible Note in the principal amount of $10,000.00 (conversion price of $2.541667 per share) and a warrant to purchase 1,333 shares of Common Stock at a purchase price of $2.50 per share.